Jason Rhodes is a partner at Atlas Venture. Jason is the chairman and was the founding chief executive officer of Generation Bio, Dyne Therapeutics (NASDAQ: DYNE), and previously Disarm Therapeutics (acquired by Lilly in 2020). He is on the boards of Replimune (NASDAQ: REPL), Be Biopharma, Gemini Therapeutics, and Accent Therapeutics. Jason rece...
Roles at Generation Bio